BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2834814)

  • 1. Biochemical and immunologic diagnosis of cancer. Lung cancer.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):134-8. PubMed ID: 2834814
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biological markers in lung cancer].
    NikliƄski J; Furman M
    Pneumonol Alergol Pol; 1991; 59(5-6):253-9. PubMed ID: 1668877
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tumor-associated antigens in bronchial cancer].
    Gropp C
    Fortschr Med; 1982 Jun; 100(23):1100-7. PubMed ID: 6286437
    [No Abstract]   [Full Text] [Related]  

  • 4. Present status of serum tumor markers in diagnosis, prognosis, and evaluation of therapy.
    Cohn SL; Lincoln ST; Rosen ST
    Cancer Invest; 1986; 4(4):305-27. PubMed ID: 2429742
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tumor markers for lung neoplasm].
    Sekido Y
    Nihon Rinsho; 2002 May; 60 Suppl 5():229-32. PubMed ID: 12101663
    [No Abstract]   [Full Text] [Related]  

  • 6. [In suspected bronchial cancer are the tumor markers neuron-specific enolase, carcinoembryonic antigen and squamous cell carcinoma antigen, of diagnostic help?].
    Jany B; Fischbach W; Chowanetz W
    Med Klin (Munich); 1988 Feb; 83(4):121-4, 158. PubMed ID: 3367874
    [No Abstract]   [Full Text] [Related]  

  • 7. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
    Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P
    Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in the diagnosis and follow-up assessment of bronchial carcinoma].
    Fischbach W
    Dtsch Med Wochenschr; 1989 May; 114(20):800-5. PubMed ID: 2656177
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor markers in bronchial carcinoma. Parameters for early diagnosis, staging and treatment follow-up].
    Gropp C; Luster W
    Ric Clin Lab; 1984; 14 Suppl 2():21-31. PubMed ID: 6099605
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical and immunologic diagnosis of cancer. Neuroblastoma.
    Collins VP; Cordon-Cardo C
    Tumour Biol; 1987; 8(2-3):143-6. PubMed ID: 3329396
    [No Abstract]   [Full Text] [Related]  

  • 11. Sialic acid, ferritin and CEA levels in peripheral blood and blood draining from the tumor in breast cancer.
    Monti M; Catania S; Locatelli E; Scazzoso A; Calzaferri G; Cunietti E
    Int J Biol Markers; 1988; 3(4):243-8. PubMed ID: 3235852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum neuron-specific enolase in patients with lung cancer].
    Matsubara Y; Yasuda Y; Yagi K; Ike O; Aoki M; Miyamoto Y; Hatakenaka R; Ninomiya K; Funatsu T; Ikeda S
    Nihon Gan Chiryo Gakkai Shi; 1985 Jul; 20(6):1136-45. PubMed ID: 2999271
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic value of pleural effusion carcinoembryonic antigen, squamous cell carcinoma related antigen and neuron-specific-enolase in patients with lung cancer].
    Fujii M; Kiura K; Kamei H; Segawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 May; 26(5):519-23. PubMed ID: 2852270
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CEA, CYFRA 21-1, NSE and CA 125 assay in serum and pleural effusion of patients with lung cancer.
    Wu GP; Ba J; Zhao YJ; Wang EH
    Acta Cytol; 2007; 51(4):679-80. PubMed ID: 17718156
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and immunologic diagnosis of cancer. Colorectal cancer.
    von Kleist S
    Tumour Biol; 1987; 8(2-3):78-83. PubMed ID: 3329404
    [No Abstract]   [Full Text] [Related]  

  • 17. Values and limits of combined use of 4 tumor markers (CEA, TPA, NSE and SCC) in un-treated patients with lung cancer.
    Cuomo A; Capra R; Greco S; Cacciani GC; Greco F; Franchini D; Bonelli P; Gavaruzzi G; Ugolotti G
    Acta Biomed Ateneo Parmense; 1993; 64(5-6):171-84. PubMed ID: 7992555
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tumor marker in lung cancer].
    Shijubo N; Abe S
    Kokyu To Junkan; 1993 Jun; 41(6):551-5. PubMed ID: 7687790
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical and immunologic diagnosis of cancer. Pancreatic and gastric cancer.
    Burtin P
    Tumour Biol; 1987; 8(2-3):84-5. PubMed ID: 2452469
    [No Abstract]   [Full Text] [Related]  

  • 20. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.